Proof-of-concept Study to Assess the Efficacy, Tolerability and Safety of a Single Intraarticular Dose of GZ389988 Versus Placebo in Patients With Painful Osteoarthritis of the Knee

Clinical trial NCT02845271 · COMPLETED

Trial details

NCT number

NCT02845271

Sponsor

Genzyme, a Sanofi Company

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2016-07-21

Primary completion

2017-06-28

Enrollment

104

View on ClinicalTrials.gov